Definitive Healthcare (DH) to Release Quarterly Earnings on Thursday

Definitive Healthcare (NASDAQ:DH - Get Free Report) is set to release its earnings data after the market closes on Thursday, November 7th. Analysts expect Definitive Healthcare to post earnings of $0.08 per share for the quarter. Definitive Healthcare has set its Q3 guidance at $0.07-0.08 EPS.Persons interested in listening to the company's conference call can do so using this link.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its quarterly earnings data on Monday, August 5th. The company reported $0.09 EPS for the quarter, hitting the consensus estimate of $0.09. The company had revenue of $63.70 million during the quarter, compared to the consensus estimate of $63.19 million. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. Definitive Healthcare's revenue for the quarter was up 4.4% on a year-over-year basis. During the same period last year, the firm earned $0.08 EPS. On average, analysts expect Definitive Healthcare to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Definitive Healthcare Stock Performance

Shares of NASDAQ:DH traded down $0.01 during trading on Thursday, hitting $4.15. 222,666 shares of the company were exchanged, compared to its average volume of 754,173. The stock has a 50 day moving average of $4.41 and a 200 day moving average of $5.14. The company has a market cap of $489.43 million, a PE ratio of -1.20, a P/E/G ratio of 6.27 and a beta of 1.33. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. Definitive Healthcare has a 52-week low of $3.19 and a 52-week high of $10.62.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Stifel Nicolaus reduced their price target on shares of Definitive Healthcare from $9.50 to $7.50 and set a "buy" rating on the stock in a research report on Wednesday, July 31st. BTIG Research started coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They issued a "buy" rating and a $7.00 target price on the stock. JPMorgan Chase & Co. lowered shares of Definitive Healthcare from a "neutral" rating to an "underweight" rating and cut their price target for the company from $7.00 to $5.00 in a research report on Wednesday, July 31st. Barclays lowered their target price on Definitive Healthcare from $6.00 to $4.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 7th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Definitive Healthcare in a research report on Tuesday, August 6th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, Definitive Healthcare currently has a consensus rating of "Hold" and an average target price of $5.81.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.